Delivery Order SPE2DR25D3004-SPE2DR26FXMF5
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,227.00 to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, a cardiovascular medication used to treat heart failure. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was issued on July 14, 2025, with an ultimate completion date of July 15, 2025. The delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,701.65 to AmerisourceBergen Drug Corp for Corlanor 7.5 mg tablets (60-count) with an ultimate completion date of November 17, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price delivery order for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the DLA's medical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,555.55 on September 24, 2025, for the supply of Corlanor 5 mg tablets (60-count units). This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by September 25, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, valued at $3,636.97. The award, made on August 26, 2025, represents a firm fixed price delivery order with an ultimate completion date of August 27, 2025. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count) valued at $2,313.94. This firm fixed-price, competitively awarded delivery order is scheduled for completion by September 19, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,199.18 to AmerisourceBergen Drug Corp for Corlanor 5 mg tablets (60-count) on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's existing federal contract portfolio with DLA. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Corlanor 5 mg tablets (60-count) with a ceiling value of $2,490.02. This is a firm fixed price delivery order with no set-aside designation, reflecting AmerisourceBergen's capability to compete in open federal procurement. The order is scheduled for ultimate completion by November 18, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,642.24 to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The contract represents a routine pharmaceutical procurement supporting federal medical supply needs...
- The Defense Logistics Agency awarded a $10,382.17 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, a cardiovascular medication used to treat heart failure. This firm fixed-price contract, awarded on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a direct purchase from the vendor's existing Indefinite Delivery Contract with DLA. The award involved no set-aside designation and was competitively awarded. Performance will occur at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets in a quantity of 60 units, with a contract value of $3,873.80. The award was made on September 29, 2025, under a firm fixed-price delivery order with an ultimate completion date of September 30, 2025. This contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXMF5Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,911.92 to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 19, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competed among qualified vendors in the open marketplace. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies to support military healthcare systems and other government medical programs worldwide. This particular order for Corlanor—a cardiovascular medication used to reduce hospitalization risk in heart failure patients—reflects the contractor's role in fulfilling specialized pharmaceutical requirements for the Defense Health Agency and related military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 11/18/25 |